Veronica Zelesky Selected Research

2- methoxy- 3- (4- (2- (5- methyl- 2- phenyloxazol- 4- yl)ethoxy)phenyl)propanoic acid

5/2009

The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veronica Zelesky Research Topics

Disease

1	Breast Neoplasms (Breast Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

1	alvocidib (flavopiridol)IBA 05/2009
1	2- methoxy- 3- (4- (2- (5- methyl- 2- phenyloxazol- 4- yl)ethoxy)phenyl)propanoic acidIBA 05/2009
1	Imatinib Mesylate (Gleevec)FDA Link 05/2009
1	Prazosin (Minipress)FDA LinkGeneric 05/2009
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2009